Feasibility of artificial-intelligence-based synthetic computed tomography in a magnetic resonance-only radiotherapy workflow for brain radiotherapy: Two-way dose validation and 2D/2D kV-image-based positioning.

Artificial intelligence Brain radiotherapy MRI-only workflow Synthetic CT kV-image-based positioning

Journal

Physics and imaging in radiation oncology
ISSN: 2405-6316
Titre abrégé: Phys Imaging Radiat Oncol
Pays: Netherlands
ID NLM: 101704276

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 15 06 2022
revised: 12 10 2022
accepted: 17 10 2022
entrez: 21 11 2022
pubmed: 22 11 2022
medline: 22 11 2022
Statut: epublish

Résumé

Magnetic Resonance Imaging (MRI)-only workflow eliminates the MRI-computed tomography (CT) registration inaccuracy, which degrades radiotherapy (RT) treatment accuracy. For an MRI-only workflow MRI sequences need to be converted to synthetic-CT (sCT). The purpose of this study was to evaluate a commercially available artificial intelligence (AI)-based sCT generation for dose calculation and 2D/2D kV-image daily positioning for brain RT workflow. T1-VIBE DIXON was acquired at the 1.5 T MRI for 26 patients in RT setup for sCTs generation. For each patient, a volumetric modulated arc therapy (VMAT) plan was optimized on the CT, then recalculated on the sCT; and vice versa. sCT-based digitally reconstructed radiographs (DRRs) were fused with stereoscopic X-ray images recorded as image guidance for clinical treatments. Dosimetric differences between planned/recalculated doses and the differences between the calculated and recorded clinical couch shift/rotation were evaluated. Mean ΔD This in-silico study showed that the AI-based sCT provided equivalent results to the CT for dose calculation and daily stereoscopic X-ray positioning when using an optimal RT setup during MRI acquisition.

Sections du résumé

Background and purpose UNASSIGNED
Magnetic Resonance Imaging (MRI)-only workflow eliminates the MRI-computed tomography (CT) registration inaccuracy, which degrades radiotherapy (RT) treatment accuracy. For an MRI-only workflow MRI sequences need to be converted to synthetic-CT (sCT). The purpose of this study was to evaluate a commercially available artificial intelligence (AI)-based sCT generation for dose calculation and 2D/2D kV-image daily positioning for brain RT workflow.
Materials and methods UNASSIGNED
T1-VIBE DIXON was acquired at the 1.5 T MRI for 26 patients in RT setup for sCTs generation. For each patient, a volumetric modulated arc therapy (VMAT) plan was optimized on the CT, then recalculated on the sCT; and vice versa. sCT-based digitally reconstructed radiographs (DRRs) were fused with stereoscopic X-ray images recorded as image guidance for clinical treatments. Dosimetric differences between planned/recalculated doses and the differences between the calculated and recorded clinical couch shift/rotation were evaluated.
Results UNASSIGNED
Mean ΔD
Conclusions UNASSIGNED
This in-silico study showed that the AI-based sCT provided equivalent results to the CT for dose calculation and daily stereoscopic X-ray positioning when using an optimal RT setup during MRI acquisition.

Identifiants

pubmed: 36405564
doi: 10.1016/j.phro.2022.10.002
pii: S2405-6316(22)00088-4
pmc: PMC9667284
doi:

Types de publication

Journal Article

Langues

eng

Pagination

111-117

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Radiother Oncol. 2008 Apr;87(1):100-9
pubmed: 18262669
Radiat Oncol. 2013 May 28;8:129
pubmed: 23714579
Strahlenther Onkol. 2020 May;196(5):444-456
pubmed: 32206842
Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):994-1003
pubmed: 30496879
Med Phys. 2016 Jan;43(1):262
pubmed: 26745919
Phys Med Biol. 2013 Dec 7;58(23):8419-35
pubmed: 24217183
Radiat Oncol. 2017 Jan 26;12(1):28
pubmed: 28126030
Radiat Oncol. 2015 Jan 10;10:13
pubmed: 25575414
Med Phys. 2012 Jun;39(6):3283-90
pubmed: 22755711
Phys Med Biol. 2013 Feb 7;58(3):465-77
pubmed: 23302471
J Appl Clin Med Phys. 2021 Mar;22(3):55-62
pubmed: 33527712
J Appl Clin Med Phys. 2019 Mar;20(3):105-114
pubmed: 30861275
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1584-9
pubmed: 20381270
Phys Med Biol. 1999 Nov;44(11):R99-155
pubmed: 10588277
Med Phys. 2016 Dec;43(12):6557
pubmed: 27908187
Phys Med Biol. 2014 Nov 7;59(21):6595-606
pubmed: 25321341
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):497-506
pubmed: 26460991
Z Med Phys. 2022 May 25;:
pubmed: 35643799
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):644-51
pubmed: 19427564
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):281-90
pubmed: 20951506
Med Dosim. 2019 Autumn;44(3):199-204
pubmed: 30115539
Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):4-21
pubmed: 34919882
Phys Med Biol. 2015 Nov 21;60(22):R323-61
pubmed: 26509844
Strahlenther Onkol. 2014 Jun;190(6):521-32
pubmed: 24715242
Acta Oncol. 2010 Oct;49(7):1085-91
pubmed: 20831500
Radiat Oncol. 2021 Apr 7;16(1):66
pubmed: 33827619
Med Phys. 2011 May;38(5):2708-14
pubmed: 21776807
Strahlenther Onkol. 2021 Mar;197(3):246-256
pubmed: 33103231
Br J Radiol. 2012 Dec;85(1020):e1256-62
pubmed: 23175491
Med Phys. 2009 Sep;36(9):3917-26
pubmed: 19810464
Technol Cancer Res Treat. 2008 Oct;7(5):341-8
pubmed: 18783283
Radiat Oncol. 2014 Jan 09;9:16
pubmed: 24405515
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):801-812
pubmed: 30108005
Acta Oncol. 2015;54(9):1496-500
pubmed: 26198652
Radiat Oncol. 2009 Nov 17;4:54
pubmed: 19919713
Radiother Oncol. 2013 Jul;108(1):118-22
pubmed: 23830190
Phys Med Biol. 2008 Jul 7;53(13):3579-93
pubmed: 18560047
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):199-217
pubmed: 29254773
Radiother Oncol. 2009 Dec;93(3):602-8
pubmed: 19846229
Strahlenther Onkol. 2020 May;196(5):417-420
pubmed: 32211940
Phys Imaging Radiat Oncol. 2020 Aug 13;15:91-97
pubmed: 33458332
Med Phys. 2014 Jan;41(1):011704
pubmed: 24387496
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1281-9
pubmed: 27209500
Med Phys. 2017 Apr;44(4):1408-1419
pubmed: 28192624
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1154-61
pubmed: 26581151
Radiother Oncol. 2016 Nov;121(2):187-192
pubmed: 27838146

Auteurs

Siti Masitho (S)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Juliane Szkitsak (J)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Johanna Grigo (J)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Rainer Fietkau (R)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Florian Putz (F)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Christoph Bert (C)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Classifications MeSH